Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Tagworks Pharmaceuticals BV
Tagworks Pharmaceuticals BV
St. Jude Children's Research Hospital
Providence Health & Services
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Alterome Therapeutics, Inc.
Pheon Therapeutics
SillaJen, Inc.
Emory University
Nuvectis Pharma, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Boehringer Ingelheim
Boehringer Ingelheim
Pheon Therapeutics
National Institutes of Health Clinical Center (CC)
Akamis Bio
Adaptimmune
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
Seattle Children's Hospital
Seattle Children's Hospital
Sichuan Baili Pharmaceutical Co., Ltd.
Washington University School of Medicine
University Health Network, Toronto
Nuvectis Pharma, Inc.
University of Pittsburgh
German Cancer Research Center
Akamis Bio
Akamis Bio
Sichuan University
Kiromic BioPharma Inc.
M.D. Anderson Cancer Center
Blueprint Medicines Corporation
Blueprint Medicines Corporation
National Cancer Institute (NCI)
Providence Health & Services
M.D. Anderson Cancer Center
West China Hospital
Keystone Nano, Inc
Advaxis, Inc.
Kyowa Kirin Co., Ltd.
Pfizer
R-Pharm
China Medical University, China
Celon Pharma SA
National Institutes of Health Clinical Center (CC)
Myeloid Therapeutics
Celgene
Multitude Therapeutics Inc.